In joints actively involved by rheumatoid arthritis, the nature of the synovial fluid is quite different from normal. The fluid is increased in volume (10 to 30 ml) and contains large numbers of leukocytes (> 10,000 per mm3) . The concentration of protein (4 to 5 g per 100 ml) is more than twice that of normal synovial fluid, whereas the concentration of hyaluronate (0.1 g per 100 ml) is reduced to one-third to one-half normal. Many studies have been made of the physical properties of rheumatoid synovial fluid (1), and although these reflect the physical state of the hyaluronate in the fluid, the hyaluronate has not been isolated for study.
In joints actively involved by rheumatoid arthritis, the nature of the synovial fluid is quite different from normal. The fluid is increased in volume (10 to 30 ml) and contains large numbers of leukocytes (> 10,000 per mm3) . The concentration of protein (4 to 5 g per 100 ml) is more than twice that of normal synovial fluid, whereas the concentration of hyaluronate (0.1 g per 100 ml) is reduced to one-third to one-half normal. Many studies have been made of the physical properties of rheumatoid synovial fluid (1) , and although these reflect the physical state of the hyaluronate in the fluid, the hyaluronate has not been isolated for study.
Recently, mild methods were described to isolate hyaluronate from normal synovial fluids (2) . Hyaluronate containing about 2% protein was obtained, and this product was called hyaluronateprotein (HP). Similar methods were used to isolate hyaluronate from rheumatoid synovial fluids, and a number of unusual findings were observed. A compound of hyaluronate combined with more protein (about 10%o) was isolated from the majority of the fluids; some of these products formed gels during dialysis in acetate buffer at pH 4.5, and all showed immobilization at the origin during zone electrophoresis at pH 4.5. None of these properties of the hyaluronate in rheumatoid synovial fluids has been previously described. During the course of these studies, the question arose whether such findings were specific for HP from rheumatoid fluids. It appears that they are not, for in a preliminary study of fluids from a few * Supported by graduate training grant 2A-5082, Na- patients with other joint diseases, HP with similar chemical analyses and physical properties was isolated from the synovial fluids of patients with chronic gout.
SUBJECTS AND METHODS
All 14 patients with rheumatoid arthritis had three well established criteria for this diagnosis: 1) chronic progressive, or recurrent, acute involvement of multiple peripheral joints with disability; 2) intermittent or persistent elevation of acute phase reactants; 3) X-ray evidence of knee joint disease showing, in mild cases, evidence of synovitis with effusion, and in severe cases, erosions of bone, cartilage loss, and ankylosis. Eight of the 14 patients had positive latex agglutination tests, three had subcutaneous nodules, and three had biopsies of the synovial membrane that showed changes compatible with rheumatoid arthritis.
The three patients with chronic gout had elevated serum uric acid levels, tophi, and X-ray evidence of lytic lesions in the bones.
Of the three other patients studied, one had chondromalacia patellae with joint effusion, one a menisceal tear with a bloody synovial effusion, and one a septic knee j oint.
Isolation of hyaluronate. Synovial fluids were aspirated from the knee joints of patients. The isolation of hyaluronate from the fluid was usually started the same day, but not later than 48 hours after aspiration. All the fluids studied had a total protein concentration exceeding that of normal synovial fluid [> 25 mg per g (1) ].
The methods used to isolate hyaluronate are described in detail elsewhere (2) . About 10 to 40 g of fluid from individual joints was diluted 1:4 with a buffer (0.04 M phosphate, 0.1 M NaCI, pH 7.2) and dialyzed at 50 C for 24 hours in 500 ml of this buffer changed twice daily. The dialyzed, diluted fluid was passed through a column of hydroxylapatite and IRC-50 cation-exchange resin. The eluate was ultrafiltered through Millipore filters of 0.1-/A pore diameter. Most of the hyaluronate was retained on the filter, and protein was progressively removed by additional ultrafiltrations and ultracentrifugations (to remove insoluble residue trapped on the Millipore filters).
Analytical methods. Hyaluronate was measured by analysis for hexuronic acid. In these pathological synovial fluids, it was necessary to reduce the protein content before such a determination could be made. A 0.5-g sample of the synovial fluid was diluted 1:4 with the phosphate-NaCl buffer and then dialyzed at 5°C for 2 days in a high ionic strength buffer (0.1 M CHCOONa, 0.4 M NaCl, acetic acid, pH 4.8) changed twice daily. Testicular hyaluronidase 1 (about 500 turbidity reducing U) was added, and the fluid incubated for 3 days at 370 C. The fluid was ultrafiltered through a collodion membrane,2 and the ultrafilterable hyaluronate fragments, free of protein, were quantitatively recovered and analyzed for hexuronic acid.
RESULTS

I. Purification of hyaluronate
Data on the ratio of protein to hyaluronate are shown in Table I . The high ratios in the pathological fluids reflect the increased concentration of plasma proteins and the reduced hyaluronate concentration compared to normal fluids. In addition, protein fractions of high molecular weight were present that did not gain entry into normal fluids (3 
III. Nature of isolated hyaluronateprotein
A stable compound of hyaluronate containing about 10%o protein was isolated from nine of fourteen patients with rheumatoid arthritis and from two of three patients with gout (Table II) .
A. Electrophoresis. The first point to establish was the firm combination of hyaluronate and protein. The products were labeled with I131 and then subjected to zone electrophoresis over a wide pH range (4.5 to 12.0). In this way, as demonstrated with HP from normal synovial fluids (2), the mobility of hyaluronate (measured as hexuronic acid) and protein (determined by radioactivity) could be compared.
Zone electrophoresis at pH 6.4, 7.4, 8.6, and 10.6 showed that hexuronic acid and protein migrated toward the anode in the same zone, indicating their firm combination (Figure 1 ). At pH 12 dissociation of the product occurred, as was noted with normal HP; unlike the normal, however, hexuronic acid migrated toward the anode ahead of the protein.
When zone electrophoresis was carried out at pH 4.5, an unexpected finding occurred: HP remained immobilized at the origin (Figure 1 At a hyaluronate concentration of 0.15 g per 100 ml, the rheumatoid product was present as a gel and did not flow; the viscosity of the normal product was readily measurable although extremely high. Upon slight dilution (hyaluronate, 0.1 g per 100 ml), the gel was transformed to a free-flowing sol, and its viscosity and that of the normal product were similar; but with further dilution the viscosity of the rheumatoid product fell sharply and progressively to very low values. Similar findings were observed in a study of HP from a patient with gout (Whe. and protein in gel formation is further evidence for a compound. Gel-sol transformation. Increasing additions of pH 4.5 buffer to the gel caused its fairly abrupt transformation to a free-flowing sol whose viscosity was markedly reduced (Figure 2) . Indeed, viscosity of the sol was much lower than the viscosity of that part of the same sample of HP which was prevented from forming a gel by prior trypsin digestion (Figure 3) . Although the nature of the association of HP chains that leads to (2) .
Whether the gel can form in vivo is, of course, unknown. Cells of the synovial membrane in rheumatoid arthritis exhibit high glycolytic activity and produce increased amounts of lactate (5, 6) , which might lower the pH locally. It is unlikely, however, that the pH can actually fall to levels low enough to induce gel formation of HP in the synovial membrane, and if the gel did form there, other factors would have to contribute as well. In this connection it has been postulated (7) that high glycolytic activity and increased lactate production in joint tissues from patients with gout can sufficiently lower the pH locally to cause further precipitations of urate crystals and continue the cycle of inflammation. SUM MARY 1) A compound of hyaluronate and protein (HP) isolated from synovial effusions obtained from patients with rheumatoid arthritis or gout showed a number of unusual properties that distinguished it from normal HP.
2) The HP from pathological effusions contained more protein (about 10%); remained immobilized at the origin during zone electrophoresis at pH 4.5; and formed a gel during dialysis in an acetate buffer, pH 4.5.
3) Evidence has been presented that the protein moiety can influence some physical properties of the hyaluronate. Trypsin digestion of HP led to migration of hyaluronate toward the anode during zone electrophoresis at pH 4.5. Digestion of HP with trypsin prevented gel formation.
4) To show that HP from pathological effusions was not an artifact of the isolation procedures, plasma proteins or leukocytes and erythrocytes were added to normal synovial fluids or to normal HP. The isolated, purified hyaluronate showed neither electrophoretic immobility nor gel formation at pH 4.5.
